Skip navigation
MOST POPULAR RELATED TAGS
  • TOPICS
  • SECTORS
  • COMPANIES

RSS FEED

» Help

Current DateTime: 09:30:11 01 Dec 2009
LinksList Documentid: 30328029

CNBC Stock Blog

Text Size
Feb.27
10:33 AM ET
Friday, 27 Feb 2009
Options Traders Love Dow Chemical

Dow Chemical faces daunting legal and business challenges but is nonetheless raising bullish speculation among options traders.



Jon "DRJ" Najarian
Cofounder, optionMonster.com

The March 7.50 calls were bought in heavy volume as DOW shares traded around $7.65 yesterday, according to OptionMonster's tracking systems. About 10,500 calls changes hands at that strike, against open interest of just 3,350 contracts.

Despite this bullish activity, the company must still address significant problems that have taken its shares [DOW  Loading...      ()   ] to their lowest levels in over 20 years. DOW is fighting a suit from Rohm & Hass for failure to close on their $15.3 billion merger, and Petrochemical Industries of Kuwait has backed out of a joint venture agreement.

The company, which operates 150 manufacturing sites in 35 countries and produces some 3,300 products, hovered above its 52-week low of $7.20 for much of the day and closed at $7.45. The stock gained back $0.07 in after-hours trading. In Friday midmorning trade, DOW lost 10 cents, at $7.35.

___________________________

Jon 'DRJ' Najarian is a professional investor, CNBC contributor, and cofounder of OptionMonster.com.

___________________________

Disclaimer

© 2009 CNBC.com

Tools:
PrintEmailAdd This share icon
Next Post
  • digg share
ADD COMMENTS
Remaining characters


Current DateTime: 05:25:10 01 Dec 2009
LinksList Documentid: 29778428

Current DateTime: 01:02:36 01 Dec 2009
LinksList Documentid: 29779196

Current DateTime: 01:31:08 01 Dec 2009
LinksList Documentid: 29779199

Current DateTime: 07:24:04 01 Dec 2009
LinksList Documentid: 29779198
  Data is a real-time snapshot  *Data is delayed at least 15 minutes
Global Business and Financial News, Stock Quotes, and Market Data and Analysis

© 2009 CNBC, Inc.  All Rights Reserved.
A Division of NBC Universal
Thomson ReutersThomson Reuters